Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Lee Jackson | Jul 28, 2014 at 8:55 AM EDT

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…

Lee Jackson | Jul 25, 2014 at 10:15 AM EDT

Credit Suisse’s Top Large-Cap Stocks Being Bought by Mutual Funds

An new report from Credit Suisse highlights the stocks where large-cap fund managers have been placing new bets the most.…

Trey Thoelcke | Jul 25, 2014 at 7:00 AM EDT

The 5 Most Heavily Shorted Nasdaq Stocks: Who Bucked the Trend?

bfishshadow via Wikimedia CommonsShort sellers shied away from four of the top five most shorted stocks on the Nasdaq between…

Jon C. Ogg | Jul 23, 2014 at 4:41 PM EDT

You Just Won’t Believe Gilead’s Profit Margins

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings…

Jon C. Ogg | Jul 20, 2014 at 9:11 AM EDT

Top Biotech Earnings Previews for the Week Ahead

ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector…

Lee Jackson | Jul 16, 2014 at 10:15 AM EDT

4 Top Biotechs Expected to Beat Earnings Expectations

In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current…

Paul Ausick | Jul 11, 2014 at 9:10 AM EDT

7 Most Heavily Shorted Nasdaq Stocks

courtesy of Sirius XM RadioHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Trey Thoelcke | Jun 25, 2014 at 7:25 AM EDT

Apple Joins the Five Most Heavily Shorted Nasdaq Stocks

A surge in short interest in Apple shares between the May 30 and June 13 settlement dates was enough to…

Trey Thoelcke | Jun 11, 2014 at 7:10 AM EDT

The Five Most Shorted Nasdaq Stocks

bfishshadow via Wikimedia CommonsShort sellers continue to hold huge positions in the same handful of Nasdaq stocks, but among them,…

Jon C. Ogg | Jun 11, 2014 at 6:50 AM EDT

Short Sellers Remain Vigilant Against Top Biotech Stocks

ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger…

Trey Thoelcke | Jun 9, 2014 at 9:25 AM EDT

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Paul Ausick | May 28, 2014 at 12:15 PM EDT

Nasdaq Stocks With the Most Short Interest

bfishshadow via Wikimedia CommonsHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short…

Jon C. Ogg | May 16, 2014 at 8:30 AM EDT

Top Biotech Stocks for Cancer Cures From Cowen

ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance…

1 … 35 36 37 38 39 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Credit Suisse’s Top Large-Cap Stocks Being Bought by Mutual Funds

The 5 Most Heavily Shorted Nasdaq Stocks: Who Bucked the Trend?

You Just Won’t Believe Gilead’s Profit Margins

Top Biotech Earnings Previews for the Week Ahead

4 Top Biotechs Expected to Beat Earnings Expectations

7 Most Heavily Shorted Nasdaq Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Apple Joins the Five Most Heavily Shorted Nasdaq Stocks

The Five Most Shorted Nasdaq Stocks

Short Sellers Remain Vigilant Against Top Biotech Stocks

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

Analyst Cancer and Biotech Stock Picks From ASCO

Nasdaq Stocks With the Most Short Interest

Top Biotech Stocks for Cancer Cures From Cowen

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Gilead Sciences : GILD

All Gilead Sciences Articles

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Credit Suisse’s Top Large-Cap Stocks Being Bought by Mutual Funds

The 5 Most Heavily Shorted Nasdaq Stocks: Who Bucked the Trend?

You Just Won’t Believe Gilead’s Profit Margins

Top Biotech Earnings Previews for the Week Ahead

4 Top Biotechs Expected to Beat Earnings Expectations

7 Most Heavily Shorted Nasdaq Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Apple Joins the Five Most Heavily Shorted Nasdaq Stocks

The Five Most Shorted Nasdaq Stocks

Short Sellers Remain Vigilant Against Top Biotech Stocks

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

Analyst Cancer and Biotech Stock Picks From ASCO

Nasdaq Stocks With the Most Short Interest

Top Biotech Stocks for Cancer Cures From Cowen

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%